This symposium aims to highlight the ways in which industry and scientists can work together to fully harness the potential of Nature's tools to treat diseases including cancer, bacterial infections and parasitic and inflammatory diseases. The use of synthetic biology to access a vast Universe of new chemical diversity is anticipated in the near future and a dialogue between chemists and biologists will be critical in achieving this.
13:30 – Registration
14:00 Prof Brad Moore, Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego USA: Genomics-inspired discovery of natural product chemistry.
14:50 Prof Maggie Smith, University of Aberdeen Proteome scanning during batch culture of Streptomyces coelicolor reveals coordinated induction of secondary metabolism pathways.
15:10 Dr Hai Deng, University of Aberdeen: Genome mining of the antibiotic dithiopyrrolone natural products
16:00 Dr Wael Houssen, University of Aberdeen: The patellamide biosynthesis – the PatA N-terminal protease.
16:20 Dr Jesko Koehnke, University of St Andrews: The patellamide biosynthesis – the PatG macrocyclase
16:40 Dr Guy Carter, ex Director Wyeth Natural Products Division, USA, Harnessing serendipity: enhanced processes for natural products drug discovery,
17:30 Wine reception